CTOs on the Move

TVA Medical

www.tvamedical.com

 
TVA Medical, Inc. is a medical device company developing innovative, minimally invasive therapies for treatment of End-Stage Renal Disease (ESRD). The company was founded by Dr. William Cohn in partnership with Sante Ventures, a life sciences venture capital firm based in Austin, TX.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.tvamedical.com
  • 7000 Bee Caves Road Suite 250
    Austin, TX USA 78746
  • Phone: 512.582.2460

Executives

Name Title Contact Details

Funding

TVA Medical raised $15M on 10/06/2015

Similar Companies

LDS Test

LDS Test is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

All-Med Services Of Fl Inc

All-Med Services Of Fl Inc is a Hialeah, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

G T S Scientific Inc

G T S Scientific Inc is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lake Region Medical

Lake Region Medical collaborates with the world’s leading medical device companies to deliver life-changing innovations that enhance the lives of patients. Backed by decades of experience and clinical expertise, we help customers bring products from concept to point-of-care in the Cardio & Vascular and Advanced Surgical markets. Lake Region Medical offers fully-integrated outsourced manufacturing and engineering services, contract manufacturing, finished device assembly, original device development and supply chain management services.

LumiThera

At LumiThera, we are committed to developing solutions to prevent vision loss and blindness, improve visual function and stop or slow the progression of blinding diseases of the eye. We will continue to innovate non-invasive approaches to address unmet medical needs. LumiThera, Inc. is a commercial-stage medical device company initially focused on treating patients affected by dry age-related macular degeneration. The Company`s expertise is in the application of photobiomodulation (“PBM”), using non-invasive light emitting diodes (“LED”) for acute and chronic ocular diseases and disorders. The Company is developing an ophthalmic LED office-based instrument to be used in multiple ocular conditions or disorders as non-invasive medical treatments. Three clinical studies have demonstrated clinical and pathological benefits of PBM in treating subjects with dry AMD. The recent TORPA II clinical trial results demonstrating improvements in clinical outcomes of vision and reduction of pathological “drusen” following imaging analysis were published in December 2016 in ACTA Ophthalmologica, a top peer-reviewed Ophthalmology journal. The company recently completed the LIGHTSITE I clinical trial,a thirty subject dry AMD study partially supported by the National Eye Institute. The Valeda LIght Delivery System is now available for sale in the European Economic Area. The Valeda Light Delivery System is CE Marked. The device is not for sale in the USA.